Novel dihydroalkoxybenzyloxopyrimidine (S-DABO) derivatives targeting the non- nucleoside inhibitor (NNI) binding site of human immunodeficiency virus (HIV) reverse transcriptase (RT) have been synthesized using a novel computer model for the NNI binding pocket and tested for their RT inhibitory activity in cell-free assays using purified recombinant HIV RT as well as for their anti-HIV activity in HTL Viiib-infected peripheral ...